Advances in the Theranostics of Oesophageal Squamous Carcinoma (Adv. Therap. 7/2023)

Abstract

Oesophageal squamous carcinoma (ESCC) is one of the most lethal human malignancies worldwide, especially in China, due to its late‐stage diagnosis, chemoradiotherapy resistance, and lack of appropriate therapeutic targets and corresponding therapeutic formulations. In article number 2200251, Bing Jiang and co‐workers review the latest genomics, diagnostics, etiology, and therapeutic researches of ESCC to provide a comprehensive discussion and seek breakthrough on the theranostics of ESCC.